Exact Sciences ticks higher amid reports HSR for Abbott deal expired
Exact Sciences (EXAS) edged higher by 0.5% amid reports the HSR waiting period for its planned sale to Abbott Laboratories...
Tag: ABT
Abbott glucose monitor sensor recall classified as most serious by FDA
The U.S. Food and Drug Administration (FDA) on Wednesday categorized a product recall initiated by Abbott Laboratories (ABT)...
Abbott Laboratories snaps six straight sessions of losses
Abbott Laboratories (ABT) shares snapped six straight sessions of losses, as the stock closed 1.2% higher at $108.77 on...
Abbott CEO purchases $2M worth of company shares
Abbott Laboratories (ABT) Chairman and CEO Robert Ford purchased 18.8K of company stock recently with a value of just over...
Abbott projects 7% organic sales growth and 10% EPS rise for 2026 as Nutrition pivots to volume recovery
Earnings Call Insights: Abbott Laboratories (ABT) Q4 2025 CEO Robert Ford highlighted that 2025 showcased "Abbott's...
Abbott drops as Nutrition unit drives Q4 revenue miss
Abbott Laboratories (ABT) lost ~5% in the premarket on Thursday after the MedTech giant reported lower-than-expected revenue...
Earnings Snapshot: Abbott Laboratories Q4 beats profit estimates, but misses on revenue; initiates Q1 and FY26 outlook
*Other Operating Data Consensus Source: Bloomberg Abbott Laboratories: Q4 Earnings On The Horizon Abbott: Not Cheap, But...
Abbott Laboratories Non-GAAP EPS of $1.50 beats by $0.01, revenue of $11.46B misses by $340M
Abbott Laboratories press release (ABT): Q4 Non-GAAP EPS of $1.50 beats by $0.01. Revenue of $11.46B (+4.5% Y/Y) misses by...
Abbott Laboratories Q4 2025 Earnings Preview
Abbott Laboratories (ABT) is scheduled to announce Q4 earnings results on Thursday, January 22nd, before market open. The...